Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1920 1
1927 1
1951 1
1975 1
1978 1
1979 1
1980 2
1983 1
1998 1
2001 1
2004 1
2005 1
2006 2
2008 1
2012 1
2016 1
2018 1
2020 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Review article: acute severe ulcerative colitis - evidence-based consensus statements.
Chen JH, Andrews JM, Kariyawasam V, Moran N, Gounder P, Collins G, Walsh AJ, Connor S, Lee TW, Koh CE, Chang J, Paramsothy S, Tattersall S, Lemberg DA, Radford-Smith G, Lawrance IC, McLachlan A, Moore GT, Corte C, Katelaris P, Leong RW; IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group. Chen JH, et al. Among authors: tattersall s. Aliment Pharmacol Ther. 2016 Jul;44(2):127-44. doi: 10.1111/apt.13670. Epub 2016 May 26. Aliment Pharmacol Ther. 2016. PMID: 27226344 Free article. Review.
A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II.
Lenti MV, Dolby V, Clark T, Hall V, Tattersall S, Fairhurst F, Kenneth C, Walker R, Kemp K, Borg-Bartolo S, Limdi JK, Taylor J, Townsend T, Subramanian S, Storey D, Assadsangabi A, Stansfield C, Smith P, Byrne D, De Silvestri A, Selinger CP. Lenti MV, et al. Among authors: tattersall s. Aliment Pharmacol Ther. 2022 Apr;55(7):856-866. doi: 10.1111/apt.16742. Epub 2021 Dec 22. Aliment Pharmacol Ther. 2022. PMID: 34935160 Free PMC article.
When to use biological agents in inflammatory bowel disease.
Corte C, Saxena P, Tattersall S, Selinger C, Leong RW. Corte C, et al. Among authors: tattersall s. J Gastroenterol Hepatol. 2012 Jul;27(7):1141-9. doi: 10.1111/j.1440-1746.2011.07056.x. J Gastroenterol Hepatol. 2012. PMID: 22188169
Systematic response to talc pleurodesis.
Gill AJ, Mathur MN, Tattersall SF. Gill AJ, et al. Among authors: tattersall sf. Am J Respir Crit Care Med. 2004 May 1;169(9):1074; author reply 1074-5. doi: 10.1164/ajrccm.169.9.958. Am J Respir Crit Care Med. 2004. PMID: 15107308 No abstract available.
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study.
Lenti MV, Levison S, Eliadou E, Willert R, Kemp K, Carter A, Stansfield C, Assadsangabi A, Singh S, Crooks B, Tattersall S, Fairhurst F, Kenneth C, Subramanian S, Probert C, Storey D, Gregg B, Smith P, Liu E, Limdi JK, Johnston A, Hamlin PJ, Selinger CP. Lenti MV, et al. Among authors: tattersall s. Dig Liver Dis. 2018 Dec;50(12):1299-1304. doi: 10.1016/j.dld.2018.07.007. Epub 2018 Jul 18. Dig Liver Dis. 2018. PMID: 30077465 Free article.
22 results